AXIS Advances Transition to Specialty Underwriter, Announces Loss Portfolio Transfer Reinsurance Agreement With Enstar on Reinsurance Segment Reserves
PEMBROKE, Bermuda–(BUSINESS WIRE)–$AXS #insurance–AXIS Capital Holdings Limited (“AXIS Capital” or “AXIS” or “the Company”) (NYSE:... Read more.
Private LTE & 5G Network Ecosystem Opportunities, Challenges, Strategies & Forecasts 2024-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Private LTE & 5G Network Ecosystem 2024-2030 – Opportunities, Challenges, Strategies, Industry Verticals... Read more.
F/m Investments Wins 2024 ThinkAdvisor Luminaries Award for Innovation
Recognition highlights F/m’s groundbreaking achievements in financial innovation, including the firm’s US Credit Series ETFs. WASHINGTON–(BUSINESS... Read more.
Boyd Watterson Names Don Haisch as Global Chief Financial Officer
CLEVELAND–(BUSINESS WIRE)–#assetmanagement–Boyd Watterson Asset Management is pleased to announce the appointment of Don Haisch as its new Global... Read more.
Alpha Cognition Announces Partial Exercise of Over-allotment Option
VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical... Read more.
Cementos Pacasmayo S.A.A. Announces CFO Succession Plans
LIMA, Peru–(BUSINESS WIRE)–Cementos Pacasmayo S.A.A. (NYSE: CPAC; BVL: CPACASC1) (“the Company” or “Cementos Pacasmayo”) announced today that... Read more.
AHF Thanks HRSA for Standing Up Against Drug Industry Attack on 340B
WASHINGTON–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) welcomes the U.S. Health Resources and Services Administration move against Sanofi’s attack... Read more.
Federal Home Loan Bank of Dallas and Community 1st Bank Las Vegas Award $9K Grant to the Las Vegas Arts Council
Funds to Promote Economic and Artistic Development LAS VEGAS, N.M.–(BUSINESS WIRE)–#affordablehousing–The Federal Home Loan Bank of Dallas (FHLB... Read more.
Merck’s KEYTRUDA® (pembrolizumab) Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy After Surgery as Adjuvant Treatment for Patients With Resectable Stage II, IIIA or IIIB NSCLC
This approval marks the fourth non-small cell lung cancer (NSCLC) indication and the first indication in earlier stages of NSCLC for KEYTRUDA in China RAHWAY, N.J.–(BUSINESS... Read more.
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for cancers with high unmet medical need This collaboration... Read more.